肾功能指标与死亡率的孟德尔随机化研究
该研究基于英国生物银行436,214名白人参与者的个体数据,采用传统观察性分析和孟德尔随机化方法,评估基于胱抑素C估算的肾小球滤过率(eGFRcyst)与全因及特定原因死亡率的因果关联。观察性分析显示eGFRcyst与所有结局呈非线性关联;孟德尔随机化分析提示,遗传预测的较低eGFRcyst与心血管死亡率升高呈线性因果关联(每降低10 mL/min/1.73m²,HR 1.43;95%CI 1.18-1.75),但未发现与全因死亡率(HR 1.07;95%CI 0.98-1.17)或非心血管死亡率有因果关联。
要点
- 遗传预测的较低eGFRcyst与心血管死亡率升高存在线性因果关联。
- 未发现eGFRcyst与全因死亡率或非心血管死亡率有因果关联。
- 观察性分析显示eGFRcyst与所有死亡率结局呈非线性关联。
核心结论
- 在一般人群中,低eGFR可能与心血管死亡率存在因果关联,但与全因死亡率或非心血管死亡率无因果关联。
研究设计与样本
- 回顾性队列研究结合孟德尔随机化,纳入英国生物银行436,214名白人参与者(54.3%女性;年龄56.8±8.0岁)。
- 采用Cox比例风险模型进行传统观察性分析,并以遗传等位基因评分作为工具变量进行线性和非线性孟德尔随机化分析。
主要发现
- 中位随访12.1年期间共发生30,489例死亡,中心血管事件6,098例、癌症15,538例、感染1,516例、其他事件7,227例。
- 传统观察性分析中,eGFRcyst与所有结局呈非线性关联。
- 孟德尔随机化分析提示,遗传预测的较低eGFRcyst与心血管死亡率升高呈线性关联(每降低10 mL/min/1.73m²,HR 1.43;95%CI 1.18-1.75)。
- 未检测到eGFRcyst与全因死亡率(HR 1.07;95%CI 0.98-1.17)或任何类型非心血管死亡率之间的因果关联。
临床怎么用
- 管理肾脏健康可能有助于降低心血管死亡率,但需谨慎解读关联幅度。
- 需在其他人群及晚期肾衰竭患者中进一步验证这些发现。
局限性
- 实际死因可能存在错误分类。
- 样本不具代表性。
- 对孟德尔随机化分析产生的关联幅度的解读可能存在误差。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: Individuals with a low estimated glomerular filtration rate (eGFR) are at a high risk of death. However, the causes underpinning this association are largely uncertain. This study aimed to assess the causal relationship of low eGFR with all-cause and cause-specific mortality. STUDY DESIGN: Retrospective cohort study incorporating Mendelian randomization (MR). SETTING & PARTICIPANTS: Individual-level data from 436,214 White participants (54.3% female; aged 56.8±8.0 years) included in the UK Biobank. EXPOSURES: eGFR estimated using cystatin C (eGFRcyst). OUTCOMES: The outcomes of interest included all-cause mortality, cardiovascular mortality, cancer mortality, infection mortality, and other-cause mortality. ANALYTICAL APPROACH: Cox proportional hazards analysis for the conventional observational analyses; linear and nonlinear MR analyses implemented using genetic allele scores as instrumental variables representing kidney function to estimate the effect of kidney function on the survival outcomes. RESULTS: During a median follow-up of 12.1 years, there were 30,489 deaths, 6,098 of which were attributed to cardiovascular events, 15,538 to cancer, 1,516 to infection, and 7,227 to other events. In the conventional observational analysis, eGFRcyst exhibited a nonlinear association with all the outcomes. MR analysis suggested that a genetically predicted lower eGFRcyst was linearly associated with a higher rate of cardiovascular mortality (HR, 1.43; 95% CI, 1.18-1.75) across the entire measurement range (every 10-mL/min/1.73m2 decrement). Nonetheless, no causal associations between eGFRcyst and all-cause mortality (HR, 1.07; 95% CI, 0.98-1.17) or any types of noncardiovascular mortality were detected. LIMITATIONS: Potential misclassification of the actual cause of death, a nonrepresentative sample, and potential error in the interpretation of the magnitude of associations generated in MR analyses. CONCLUSIONS: These findings suggest a potential causal association between low eGFR and cardiovascular mortality in the general population, but no causal relationship with all-cause mortality or noncardiovascular mortality was observed. Further studies in other populations are warranted to confirm these findings. PLAIN-LANGUAGE SUMMARY: This study investigated the existence of a causal relationship between lower kidney function and death of different causes. Using data from 436,214 people in the United Kingdom, we applied conventional statistical analyses and those incorporating genetic data to implement Mendelian randomization, an approach that estimates causal associations. The observational analysis showed a nonlinear association between kidney function and various types of mortality outcomes. However, Mendelian randomization analysis suggested a linear increase in the risk of cardiovascular mortality with lower kidney function, but no causal link between the level of kidney function and all-cause or noncardiovascular mortality was identified. Managing kidney health may help reduce cardiovascular mortality, but caution is needed in interpreting the magnitudes of these results. Further validation in other populations and in those with advanced kidney failure is needed.
引用
- Shan Y, Zhang J, Lu Y, et al. Kidney Function Measures and Mortality: A Mendelian Randomization Study. Am J Kidney Dis. 2023. PMID: 38151225. doi:10.1053/j.ajkd.2023.10.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。